Abstract
Manganese-enhanced magnetic resonance imaging (MEMRI) enables tract tracing to follow neural pathways through axonal transport. However, the method is problematic because of the high local concentrations of Mn(2+) involved. We developed a tetrananogel containing a dextran-manganese complex (Dex-Mn-Gel) and applied this nanogel to rats. MnCl(2) (n = 5), Dex-Mn-Gel (n = 5), or saline control (n = 3) was injected into the left knee joint of the rats (n = 13). Inflammation and tissue alterations in the knee joint were also evaluated histologically. T1-weighted images were obtained on a 7 T MRI system 24 hours after the administration and compared across groups. The sciatic nerve in both legs and the surrounding musculature were used as regions of interest (ROI). No swelling was found in the knee joint infused with Dex-Mn-Gel, although prominent swelling of the knee joint was observed with MnCl(2). White blood cells inside the knee joint tissue infused with the Dex-Mn-Gel were significantly less abundant (45%, P < .05) compared with the knee joints infused with MnCl(2). Visualization of the sciatic nerve was significantly enhanced in rats treated with both forms of Mn(2+) compared with controls (P < .01). This study is the first to attempt intra-articular administration of a manganese contrast agent into joint-capsule and demonstrate tract visualization. The Dex-Mn-Gel can be taken up by the nerve endings and reduce Mn(2+) toxicity. Dex-Mn-Gel will provide a minimally invasive method for visualizing nerve tracts in vivo.